PremiumThe FlyT2 Biosystems achieves milestone with 250,000th novel sepsis test shipped T2 Biosystems extends multi-year supplier agreement with Vizient T2 Biosystems Advances Sepsis Detection Technology Licensing PremiumThe FlyArcadium confirms Rio approach, Apollo funds to acquire Barnes: Morning Buzz T2 Biosystems sees Q3 revenue $2M, up 35% compared to 3Q23 T2 Biosystems sees Q4 sepsis product revenue $2.5M-$3.5M PremiumCompany AnnouncementsT2 Biosystems Gains FDA Nod for Pediatric Sepsis Test T2 Biosystems receives FDA clearance to market the T2Candida Panel T2 Biosystems: Pioneering Rapid Diagnostic Tests Launch 
